NEW RECOMMENDATIONS ON CHILDREN'S COUGH AND COLD TREATMENTS
The makers of CALPOL® and other manufacturers are updating the labels on their children's cough and cold medicines to reflect new advice from the Medicines and Healthcare products Regulatory Agency (MHRA) stating that they "should not be used" in children under 6 years. This new advice applies to the following products from the makers of CALPOL®:
- CALCOLD® (contains paracetamol and diphenhydramine)
- CALCOUGH® Chesty (contains guaifenesin)
- CALPOL® Night (contains paracetamol and diphenhydramine)
If you are unsure about whether a cough or cold medicine is appropriate for your child, speak to your pharmacist or GP before using the medicine.
All other CALPOL® products are unaffected. Always read the label.
Click here for more information on the CALPOL® products that are unaffected by the MHRA changes.
